INTEGRAL BIOSYSTEMS, LLC

Capabilities

Capabilities Statement Integral BioSystems, LLC is owned and led by a minority woman since its founding in 2009, with expertise in drug R&D, available to assist primary contractors and the NIH (and other appropriate government agencies) by providing the following services: • Analytical method development • Analytical method qualification • Formulation development • Process Development and Scale up • ICH Stability Studies • USP IV Flow-through IVRT studies • Toxicology clean supplies and cGLP release testing • Bioanalytical method development • Scale-up and Technology Transfer • Ophthalmic, Otic, Dermal and Sublingual Route expertise • Extensive expertise in sustained release delivery systems • Extensive subject matter expertise in ophthalmic drug delivery with subject matter expertise with lipid nanoparticles and PLGA microspheres • Oral films to deliver vaccines DUNS: 786575287; Cage code-6SVP3; NAICS CODE-541714 Will Accept Credit Cards